Tissue Engineering & 3D Bioprinting represents a revolutionary convergence of biomaterials, cellular biology, and digital fabrication technologies aimed at constructing functional tissues for therapeutic and research applications. Using bioinks composed of living cells and supportive matrices, scientists are now printing complex, multi-layered structures that mimic natural tissue architecture. This technique enables patient-specific constructs for skin, bone, cartilage, and even organ precursors. Tissue Engineering & 3D Bioprinting also supports advancements in disease modeling and drug screening by producing physiologically relevant tissue analogs. Innovations in scaffold design, vascularization, and bioprinter resolution continue to overcome previous limitations, moving the field closer to fully implantable and vascularized organs. Its implications span regenerative medicine, personalized implants, and fundamental biological research.
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Ancient wisdom, modern science: Biotech services transforming ayurveda
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain